Armodafinil 50 Mg: Understanding Its Medical Uses, Wakefulness And Treatment

By Author: gracewhite
Total Articles: 1
Comment this article

Introduction

Armodafinil 50 mg is a prescription formulation of armodafinil, a wakefulness-promoting medicine used for specific sleep-related conditions. It is primarily associated with the management of excessive daytime sleepiness rather than ordinary tiredness or occasional lack of sleep.

In Australia, the Therapeutic Goods Administration (TGA) has an active ARTG entry for NUVIGIL armodafinil 50 mg tablets. Armodafinil-TEVA 50 mg tablets are also listed in the ARTG.

Understanding the medical purpose of armodafinil is important because the medicine is intended for particular sleep disorders and should be used according to prescription instructions.

What Is Armodafinil?

Armodafinil is the R-enantiomer of modafinil and belongs to a group of medicines that promote wakefulness. Australian product information describes it as a wakefulness-promoting agent for oral administration. Available NUVIGIL tablet strengths include 50 mg, 150 mg and 250 mg.

Its precise mechanism of action is not completely understood, although its effects involve activity within the central nervous system.

The ...
... purpose of treatment is to improve wakefulness when excessive daytime sleepiness is associated with an appropriate medical condition.

What Is Armodafinil 50 mg Used For?

Australian Consumer Medicine Information states that NUVIGIL is used to improve wakefulness in people with excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnoea/hypopnoea syndrome (OSAHS), or shift work sleep disorder (SWSD).

For narcolepsy, the medicine helps reduce unwanted excessive daytime sleepiness. In OSAHS, it can be used alongside CPAP to improve wakefulness. For moderate-to-severe chronic shift work sleep disorder, it may be prescribed when non-drug approaches have been unsuitable or unsuccessful.

These are specific therapeutic uses and are different from taking armodafinil simply to feel more energetic.

Armodafinil for Narcolepsy

Narcolepsy is a sleep disorder that can cause an excessive and sometimes irresistible tendency to fall asleep during normal waking hours.

For people with narcolepsy, excessive sleepiness can interfere with work, study, travel and other daily activities. Armodafinil is used to improve wakefulness and reduce this unwanted daytime sleepiness.

The medicine does not replace normal sleep. Its purpose is to help manage excessive sleepiness associated with the underlying sleep disorder.

Armodafinil and Shift Work Sleep Disorder

Working night shifts or rotating shifts can disturb the normal sleep-wake cycle. In some people, this can develop into chronic shift work sleep disorder, which may involve significant sleepiness during working hours.

Armodafinil may be used for moderate-to-severe chronic shift work sleep disorder when non-pharmacological interventions have been unsuccessful or inappropriate.

Simply working at night does not automatically mean that someone has shift work sleep disorder. Persistent sleepiness should be evaluated in relation to the person's sleep pattern, work schedule and symptoms.

Armodafinil and Obstructive Sleep Apnoea

Obstructive sleep apnoea/hypopnoea syndrome can interrupt normal sleep and contribute to excessive daytime sleepiness.

In appropriate patients, armodafinil can be used as an adjunct to continuous positive airway pressure (CPAP) to improve wakefulness. It does not treat the underlying airway obstruction itself. The Australian CMI advises that treatment for the underlying condition, such as CPAP, should continue unless otherwise instructed.

This distinction is important because improving daytime wakefulness does not mean that the underlying sleep-apnoea condition has been corrected.

Is 50 mg the Usual Treatment Amount?

The availability of a 50 mg tablet does not mean that 50 mg is the usual treatment amount for every condition.

The Australian CMI confirms that NUVIGIL tablets contain 50 mg, 150 mg or 250 mg of armodafinil. It states that the usual daily dose depends on individual response. For sleepiness associated with narcolepsy or OSAHS, the listed range is 150 mg to 250 mg, while 150 mg is recommended for shift work sleep disorder.

Therefore, the 50 mg formulation should not be selected independently based only on the tablet strength. The prescribed amount should be followed as directed.

Armodafinil and Daytime Alertness

The main therapeutic goal of armodafinil is wakefulness. Someone experiencing excessive sleepiness because of a diagnosed sleep disorder may find it easier to remain awake during normal daytime activities when treatment is effective.

This does not make armodafinil a general energy supplement. Persistent tiredness caused by insufficient sleep should not automatically be treated with a prescription wakefulness medicine.

If daytime sleepiness occurs regularly, identifying the underlying cause is an important part of appropriate care.

Important Treatment Considerations

Armodafinil is a prescription medicine, so its suitability depends on individual circumstances. The Australian CMI recommends discussing relevant medical conditions and other medicines before treatment. This includes conditions involving the heart, blood pressure, liver or kidneys, as well as certain mental-health conditions and interactions with other medicines.

The CMI also notes that armodafinil can reduce the effectiveness of hormonal contraceptives during treatment and for two months after stopping treatment.

Because individual circumstances can vary, prescription instructions and the official Consumer Medicine Information should be followed rather than relying on general online dosing advice.

Armodafinil 50 mg in Australia

The TGA's Australian Register of Therapeutic Goods is the public database for therapeutic goods that can be legally supplied in Australia. The current ARTG record lists NUVIGIL armodafinil 50 mg tablet blister pack under ARTG ID 272052.

ARMODAFINIL-TEVA 50 mg tablet blister pack is also listed under ARTG ID 404160.

Checking the ARTG can therefore be useful when researching an armodafinil product and its Australian regulatory information.

Conclusion

Armodafinil 50 mg is a prescription wakefulness-promoting formulation used in the management of excessive daytime sleepiness associated with specific conditions, including narcolepsy, chronic shift work sleep disorder and obstructive sleep apnoea/hypopnoea syndrome.

https://www.armodafinil.com.au/product/artvigil-50-mg